OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
14.24
-0.41 (-2.80%)
Dec 5, 2025, 4:00 PM EST - Market closed
OptimizeRx Revenue
OptimizeRx had revenue of $26.07M in the quarter ending September 30, 2025, with 22.33% growth. This brings the company's revenue in the last twelve months to $109.51M, up 24.18% year-over-year. In the year 2024, OptimizeRx had annual revenue of $92.13M with 28.81% growth.
Revenue (ttm)
$109.51M
Revenue Growth
+24.18%
P/S Ratio
2.41
Revenue / Employee
$848,884
Employees
129
Market Cap
265.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 92.13M | 20.61M | 28.81% |
| Dec 31, 2023 | 71.52M | 9.07M | 14.53% |
| Dec 31, 2022 | 62.45M | 1.16M | 1.89% |
| Dec 31, 2021 | 61.29M | 17.98M | 41.51% |
| Dec 31, 2020 | 43.31M | 18.72M | 76.08% |
| Dec 31, 2019 | 24.60M | 3.39M | 15.99% |
| Dec 31, 2018 | 21.21M | 9.08M | 74.86% |
| Dec 31, 2017 | 12.13M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 7.22M | 717.72K | 11.04% |
| Dec 31, 2014 | 6.50M | 1.82M | 38.96% |
| Dec 31, 2013 | 4.68M | 2.69M | 135.27% |
| Dec 31, 2012 | 1.99M | 877.57K | 78.95% |
| Dec 31, 2011 | 1.11M | 1.04M | 1,464.09% |
| Dec 31, 2010 | 71.07K | 44.34K | 165.93% |
| Dec 31, 2009 | 26.72K | -56.96K | -68.07% |
| Dec 31, 2008 | 83.69K | -16.63K | -16.58% |
| Dec 31, 2007 | 100.32K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
OPRX News
- 4 weeks ago - OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance - GlobeNewsWire
- 6 weeks ago - OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET - GlobeNewsWire
- 2 months ago - 4 Top AI-Powered Healthcare Stocks - Seeking Alpha
- 2 months ago - OptimizeRx: How The Stock Is Changing Pharma Marketing - Seeking Alpha
- 3 months ago - OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference - GlobeNewsWire
- 3 months ago - OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising - GlobeNewsWire
- 3 months ago - OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth - GlobeNewsWire